Association Between Smell Loss, Disease Burden, and Dupilumab Efficacy in Chronic Rhinosinusitis with Nasal Polyps.

Am J Rhinol Allergy · 2025 · PMC11626849 · PMID 39300794

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Looking at Week 52 (SINUS-52 study only), a similar pattern of results was seen except that the difference in magnitude of improvement in RS-VAS with dupilumab between LoS subgroups did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.